...
首页> 外文期刊>Molecular Therapy - Methods & Clinical Development >Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
【24h】

Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing

机译:整合酶缺陷的慢病毒载体作为高效CRISPR / CAS9介导的基因编辑的一体化平台

获取原文
           

摘要

The CRISPR/Cas9 systems have revolutionized the field of genome editing by providing unprecedented control over gene sequences and gene expression in many species, including humans. Lentiviral vectors (LVs) are one of the primary delivery platforms for the CRISPR/Cas9 system due to their ability to accommodate large DNA payloads and sustain robust expression in a wide range of dividing and non-dividing cells. However, long-term expression of LV-delivered Cas9/guide RNA may lead to undesirable off-target effects characterized by non-specific RNA-DNA interactions and off-target DNA cleavages. Integrase-deficient lentiviral vectors (IDLVs) present an attractive means for delivery of CRISPR/Cas9 components because: (1) they are capable of transducing a broad range of?cells and tissues, (2) have superior packaging capacity compared to other vectors (e.g., adeno-associated viral vectors), and (3) they are expressed transiently and demonstrate very weak integration capability. In this manuscript, we aimed to establish IDLVs as a means for safe and efficient delivery of CRISPR/Cas9. To this end, we developed an all-in-one vector cassette with increased production efficacy and demonstrated that CRISPR/Cas9 delivered by the improved IDLV vectors?can mediate rapid and robust gene editing in human embryonic kidney (HEK293T) cells and post-mitotic brain neurons in?vivo, via transient expression and with higher gene-targeting specificity than the corresponding integrase-competent vectors.
机译:CRISPR / CAS9系统通过在许多物种(包括人)中,通过提供前所未有的对基因序列和基因表达来彻底改变了基因组编辑领域。慢病毒载体(LVS)是CRISPR / CAS9系统的主要交付平台,因为它们能够容纳大型DNA有效载荷并在广泛的分割和非分区细胞中维持鲁棒表达。然而,LV输送的CAS9 /引导RNA的长期表达可能导致不希望的偏离目标效果,其特征是非特异性RNA-DNA相互作用和偏离靶DNA裂解。整合酶缺陷的慢病毒载体(IDLV)提出了一种用于递送CRISPR / CAS9组件的有吸引力的手段,因为:(1)它们能够转换各种Δ细胞和组织,(2)与其他载体相比具有卓越的包装能力(例如,腺相关的病毒载体)和(3)它们瞬时表达并表现出非常弱的集成能力。在本手稿中,我们旨在建立IDLV作为安全有效地提供CRISPR / CAS9的手段。为此,我们开发了一体化的传染媒介盒,增加了生产疗效,并证明了通过改进的IDLV载体提供的CRISPR / CAS9?可以在人胚胎肾(HEK293T)细胞中介绍快速和鲁棒的基因编辑和后型患者脑神经元在α体内,通过瞬时表达和具有高于相应的整合酶富集的载体的基因靶向特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号